Home> Products> mechanism of action of linagliptin dpp 4 inhibitor

{ "products": [ { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-01-15T06:43:31.028Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6990397c160585bfd7038bed", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Baclofen Sustained Release 30 mg", "description": "BACLOFINE SR 30: Comprehensive Product Guide\nProduct Overview\nBACLOFINE SR 30 is an advanced pharmaceutical formulation containing Baclofen 30 mg in a sustained-release delivery system. This prescription medication represents a significant advancement in the management of muscle spasticity and related neuromuscular conditions. The sustained-release technology ensures consistent therapeutic effects throughout the day, providing patients with improved symptom control and enhanced quality of life.\nBaclofen, the active pharmaceutical ingredient in BACLOFINE SR 30, belongs to a class of medications known as skeletal muscle relaxants and antispasmodic agents. The SR (Sustained Release) formulation is specifically engineered to release the medication gradually over an extended period, maintaining steady blood levels and reducing the frequency of dosing compared to conventional immediate-release formulations.\nMechanism of Action and Therapeutic Use\nBACLOFINE SR 30 works by acting on the central nervous system, specifically targeting GABA-B receptors in the spinal cord and brain. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the nervous system. By stimulating these receptors, Baclofen reduces the excessive nerve signals that cause muscles to contract involuntarily, thereby alleviating spasticity and associated discomfort.\nThe sustained-release technology incorporated in BACLOFINE SR 30 utilizes advanced polymer-based matrices that control the rate at which the active ingredient is released into the bloodstream. This innovative approach ensures that patients receive consistent therapeutic coverage for up to 12-24 hours from a single dose, eliminating the peaks and troughs associated with immediate-release formulations.\nPrimary Indications\nBACLOFINE SR 30 is primarily prescribed for managing muscle spasticity associated with various neurological conditions including multiple sclerosis, spinal cord injuries, cerebral palsy, stroke, brain injuries, and other conditions affecting the central nervous system. The medication is particularly beneficial for patients experiencing painful muscle spasms, stiffness, and involuntary muscle contractions that interfere with daily activities, mobility, and rehabilitation efforts.\nKey Benefits of BACLOFINE SR 30\nExtended Duration of Action\nThe most significant advantage of BACLOFINE SR 30 is its sustained-release formulation, which provides prolonged therapeutic effects. Patients typically require only one or two doses per day, compared to three or four doses with conventional formulations. This extended duration improves medication adherence and provides more consistent symptom control throughout the day and night.\nImproved Symptom Management\nBy maintaining steady blood levels of Baclofen, BACLOFINE SR 30 delivers superior control of muscle spasticity with fewer fluctuations in symptom relief. Patients experience reduced muscle stiffness, decreased frequency and severity of muscle spasms, improved range of motion, and enhanced ability to participate in physical therapy and rehabilitation programs.\nEnhanced Quality of Life\nThe consistent therapeutic effects of BACLOFINE SR 30 translate into meaningful improvements in daily functioning. Patients often report better sleep quality due to reduced nighttime spasms, improved mobility and independence in performing daily activities, reduced pain and discomfort associated with muscle spasticity, and greater participation in social and recreational activities.\nReduced Dosing Frequency\nThe sustained-release technology means fewer doses throughout the day, which simplifies medication regimens and improves compliance, particularly for patients managing multiple medications. This convenience factor is especially valuable for individuals with cognitive impairments or those who require caregiver assistance with medication administration.\nSmoother Therapeutic Response\nUnlike immediate-release formulations that can cause pronounced peaks in drug levels, BACLOFINE SR 30 provides a more gradual and sustained therapeutic effect. This results in reduced risk of dose-related side effects, more stable muscle relaxation throughout the dosing interval, and minimized breakthrough spasticity between doses.\nPotential Side Effects and Considerations\nWhile BACLOFINE SR 30 is generally well-tolerated, patients should be aware of potential side effects. It's important to note that not everyone experiences these effects, and many side effects diminish as the body adjusts to the medication.\nCommon Side Effects\nThe most frequently reported side effects include drowsiness and sedation, which typically occur during initial therapy or dose adjustments. Patients may also experience dizziness, fatigue, weakness, headache, nausea, and constipation. These effects are usually mild to moderate and often resolve within the first few weeks of treatment.\nCentral Nervous System Effects\nSome patients may experience confusion, particularly elderly individuals, difficulty concentrating, insomnia or sleep disturbances, and mood changes. These effects should be monitored and reported to healthcare providers if they persist or worsen.\nCardiovascular and Other Effects\nOccasional side effects may include hypotension (low blood pressure), urinary frequency or retention, dry mouth, and muscle weakness beyond the intended therapeutic effect.\nSerious Considerations\nPatients should seek immediate medical attention if they experience severe allergic reactions, hallucinations or severe confusion, difficulty breathing, severe muscle weakness affecting breathing or swallowing, or signs of overdose including extreme drowsiness, respiratory depression, or seizures.\nImportant Warnings\nBACLOFINE SR 30 should never be discontinued abruptly without medical supervision, as sudden withdrawal can lead to serious complications including seizures, hallucinations, increased spasticity, and other potentially life-threatening symptoms. Dose reduction must be gradual and carefully supervised by a healthcare provider.\nThe medication may cause drowsiness and impair mental alertness, so patients should avoid driving, operating machinery, or engaging in activities requiring full alertness until they understand how the medication affects them. Alcohol and other central nervous system depressants should be avoided or used with extreme caution, as they can potentiate the sedative effects of Baclofen.\nDosage and Administration Guidelines\nBACLOFINE SR 30 should be taken exactly as prescribed by a healthcare provider. The tablets should be swallowed whole and not crushed, chewed, or broken, as this would compromise the sustained-release mechanism and potentially lead to dose dumping. The medication can be taken with or without food, though taking it with food may help reduce gastrointestinal side effects.\nDosage is highly individualized based on the patient's condition, response to treatment, and tolerance. Healthcare providers typically initiate therapy at lower doses and gradually titrate upward to achieve optimal therapeutic effects while minimizing side effects.\nConclusion\nBACLOFINE SR 30 represents a sophisticated therapeutic option for individuals struggling with muscle spasticity and related neuromuscular conditions. The sustained-release formulation offers distinct advantages over conventional immediate-release preparations, including extended duration of action, improved symptom control, reduced dosing frequency, and enhanced patient convenience and compliance.", "price": 245.0, "discountamount": 74.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2306, "imageuri": "https://productimages.withfloats.com/actual/6990397eb2070251db7032d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6990397eb2070251db7032d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-14T08:59:40.632Z", "updatedon": "2026-02-14T09:20:07.895Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/baclofen-sustained-release-30-mg/2306", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BACLOFINE SR 30", "category": "NEUROLOGYRANGE", "tags": [ "baclofen sr 30 mg tablet uses", "what is baclofen sr 30 prescribed for", "baclofen sr 30 mg dosage guide", "baclofen sr 30 mg for back pain", "baclofen sr 30 mg vs regular baclofen", "baclofen sr 30 mg for spinal cord injury", "baclofen sr 30 mg side effects in adults", "is baclofen sr 30 mg addictive", "buy baclofen sr 30 mg online", "baclofen sr 30 mg manufacturer", "baclofen sr 30 mg prescription required", "baclofen sr 30 mg vs baclofen 10 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "698af4f53f78e8d74694007f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "rosuvastatin ezetimibe 40 10 mg", "description": "REVOSTATIN EZ 40 is a fixed-dose combination of Rosuvastatin 40 mg and Ezetimibe 10 mg, formulated to provide advanced and effective management of high cholesterol levels. This powerful dual-action therapy is prescribed for patients who require intensive lipid-lowering treatment, particularly those at high risk of cardiovascular diseases.\n\nHigh cholesterol, especially elevated LDL (bad cholesterol), is a major contributor to heart attacks, strokes, and atherosclerosis. REVOSTATIN EZ 40 works through two complementary mechanisms—reducing cholesterol production in the liver and limiting cholesterol absorption from the intestine—offering superior cholesterol control compared to single-agent therapy.\n\nProduct Description\n\nREVOSTATIN EZ 40 combines a high-potency statin with a cholesterol absorption inhibitor to deliver comprehensive lipid management. Rosuvastatin belongs to the statin class of medicines, while Ezetimibe selectively blocks cholesterol uptake in the digestive tract. Together, they significantly reduce LDL cholesterol, total cholesterol, and triglycerides, while helping maintain or modestly increase HDL (good cholesterol).\n\nThis combination is especially beneficial for patients who do not achieve target cholesterol levels with statin therapy alone or those with a high cardiovascular risk profile. REVOSTATIN EZ 40 is typically prescribed alongside lifestyle modifications such as a cholesterol-controlled diet, regular exercise, and weight management.\n\nUses of REVOSTATIN EZ 40\n\nREVOSTATIN EZ 40 is indicated for the treatment and management of:\n\n1. Primary Hypercholesterolemia\n\nUsed in patients with high LDL cholesterol levels that are not adequately controlled by diet and exercise alone.\n\n2. Mixed Dyslipidemia\n\nHelps manage elevated cholesterol and triglyceride levels simultaneously.\n\n3. Prevention of Cardiovascular Diseases\n\nReduces the risk of heart attack, stroke, and other cardiovascular events in high-risk individuals, including patients with diabetes, hypertension, or a history of heart disease.\n\n4. Familial Hypercholesterolemia\n\nPrescribed in certain cases of inherited cholesterol disorders where aggressive lipid lowering is required.\n\nHow REVOSTATIN EZ 40 Works\n\nThe effectiveness of REVOSTATIN EZ 40 lies in its dual mechanism of action:\n\nRosuvastatin\n\nInhibits HMG-CoA reductase, an enzyme responsible for cholesterol synthesis in the liver\n\nReduces LDL cholesterol and triglycerides\n\nImproves overall lipid profile\n\nStabilizes plaque in blood vessels, reducing cardiovascular risk\n\nEzetimibe\n\nBlocks the absorption of cholesterol from the small intestine\n\nReduces the amount of cholesterol delivered to the liver\n\nEnhances the cholesterol-lowering effect of statins\n\nBy targeting both cholesterol production and absorption, REVOSTATIN EZ 40 delivers deeper and more sustained cholesterol reduction.\n\nKey Benefits of REVOSTATIN EZ 40\n1. Superior LDL Cholesterol Reduction\n\nThe combination therapy offers significantly greater LDL lowering compared to statin monotherapy.\n\n2. Comprehensive Lipid Control\n\nEffectively reduces total cholesterol and triglycerides while supporting healthy HDL levels.\n\n3. Reduced Cardiovascular Risk\n\nHelps lower the risk of heart attacks, strokes, and other serious heart-related complications.\n\n4. Effective for High-Risk Patients\n\nIdeal for patients with diabetes, obesity, smoking history, or established cardiovascular disease.\n\n5. Convenient Combination Therapy\n\nCombines two powerful lipid-lowering agents in a single tablet, improving treatment adherence.\n\nSide Effects of REVOSTATIN EZ 40\n\nLike all medications, REVOSTATIN EZ 40 may cause side effects in some individuals. Most are mild to moderate and tend to improve with continued use.\n\nCommon Side Effects\n\nHeadache\n\nMuscle pain or weakness\n\nAbdominal discomfort\n\nNausea or indigestion\n\nFatigue\n\nMild increases in liver enzymes\n\nThese effects are usually temporary and manageable under medical supervision.\n\nLess Common but Serious Side Effects\n\nSeek immediate medical advice if you experience:\n\nSevere muscle pain or tenderness\n\nDark-colored urine\n\nUnusual fatigue or weakness\n\nYellowing of the skin or eyes (jaundice)\n\nAllergic reactions such as rash, itching, or swelling\n\nRegular monitoring of liver function and lipid levels is recommended during treatment.\n\nPrecautions and Safety Information\n\nREVOSTATIN EZ 40 should be taken exactly as prescribed by a healthcare professional.\n\nInform your doctor if you have liver disease, kidney problems, or a history of muscle disorders.\n\nAvoid excessive alcohol consumption during treatment.\n\nPregnant and breastfeeding women should not use this medication.\n\nContinue a cholesterol-lowering diet and healthy lifestyle for optimal results.\nConclusion\nREVOSTATIN EZ 40 (Rosuvastatin 40 mg and Ezetimibe 10 mg) is a highly effective and well-tolerated combination therapy designed for advanced cholesterol management. By addressing cholesterol from two critical pathways—production and absorption—it offers superior lipid control and enhanced cardiovascular protection.", "price": 265.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2299, "imageuri": "https://productimages.withfloats.com/actual/698af4fc8c165a34c7ef1b78.png", "tileimageuri": "https://productimages.withfloats.com/tile/698af4fc8c165a34c7ef1b78.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-10T09:05:57.148Z", "updatedon": "2026-02-12T09:57:12.812Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rosuvastatin-ezetimibe-40-10-mg/2299", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REVOSTATIN EZ 40", "category": "CARDIOLOGYRANGE", "tags": [ "rosuvastatin ezetimibe 40 10 mg uses", "what is rosuvastatin ezetimibe 40/10 mg used for", "rosuvastatin ezetimibe combination benefits", "rosuvastatin ezetimibe tablets composition", "when to take rosuvastatin ezetimibe 40 10 mg", "rosuvastatin ezetimibe 40 10 mg side effects", "rosuvastatin ezetimibe interaction with food", "rosuvastatin ezetimibe 40 10 mg tablet price", "rosuvastatin ezetimibe 40/10 mg brand", "rosuvastatin ezetimibe 40 10 mg tablet cost", "rosuvastatin ezetimibe 40 10 mg manufacturer", "rosuvastatin ezetimibe 40/10 mg vs rosuvastatin 40 mg", "rosuvastatin ezetimibe 40 10 mg india", "rosuvastatin ezetimibe manufacturer india", "rosuvastatin ezetimibe 40 10 mg dosage for elderly", "rosuvastatin ezetimibe liver function monitoring" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6958dbfa1063d98b1e8f2fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benidipine 4mg", "description": "BENIPRIME 4, containing Benidipine 4 mg, offers effective management for high blood pressure and related heart conditions. This calcium channel blocker helps relax blood vessels to improve blood flow and reduce strain on the heart. Patients often find it reliable for daily control of hypertension symptoms.\n\nWhat is BENIPRIME 4?\nBENIPRIME 4 is a branded tablet from Steris Healthcare Pvt Ltd, featuring 4 mg of Benidipine as the active ingredient. Benidipine belongs to the dihydropyridine class of calcium channel blockers, designed specifically for cardiovascular health. Each tablet delivers a precise dose in a user-friendly form, typically packaged in strips of 10 for convenient use. Manufactured under strict quality standards, it targets essential needs in hypertension care, making it a staple in many treatment plans across India.\n​\n\nThis medication stands out due to its triple action on L-type, N-type, and T-type calcium channels, providing broader vascular protection compared to some other blockers. Doctors prescribe it for adults dealing with persistent high blood pressure or chest pain, often starting at this 4 mg strength for balanced efficacy. Unlike generic options, BENIPRIME 4 ensures consistent absorption and formulation tailored for Indian patients, with pricing around Rs 62-89 per strip after discounts.\n​\n\nHow BENIPRIME 4 Works\nBenidipine in BENIPRIME 4 blocks calcium entry into smooth muscle cells of blood vessels and heart muscles. This action causes vasodilation, widening arteries to lower resistance and ease blood flow. By reducing systolic and diastolic pressure, it lightens the heart's workload without drastically slowing the heartbeat.\n​\n\nThe unique blockade of multiple calcium channels also boosts nitric oxide production, offering antioxidant effects and protection against artery hardening. This sustained mechanism provides 24-hour control, ideal for once-daily dosing after breakfast. Over time, it may even reduce urinary protein and triglycerides, supporting kidney and metabolic health in hypertensives.\n​\n\nKey Uses of BENIPRIME 4\nBENIPRIME 4 primarily treats essential hypertension, helping prevent strokes, heart attacks, and kidney damage. It effectively manages angina pectoris by enhancing coronary blood supply, reducing chest pain episodes during activity.\n​\n\nPhysicians also use it for renal parenchymal hypertension, where kidney issues elevate blood pressure. In emergencies like hypertensive crises or subarachnoid hemorrhage, higher doses prove beneficial, though 4mg serves as maintenance. For arrhythmia or anal fissures linked to vascular strain, it offers supportive relief.\n​\n\nLowers high blood pressure in adults, including severe cases with dose adjustments.\n​\n\nEases angina symptoms, improving exercise tolerance and daily life quality.\n​\n\nProtects renal function in proteinuric patients by stabilizing vessels.\n​\n\nDosage and Administration\nTake BENIPRIME 4 as 4 mg once daily, swallowed whole after a meal to minimize stomach upset. Doctors may adjust to 2-8mg based on response, age, or kidney/liver status, never exceeding 8 mg daily without monitoring. Consistency in timing ensures steady levels for optimal pressure control.\n​\n\nMissed doses require prompt intake if remembered soon, but skip if near the next one—avoid doubles. Pair with lifestyle changes like low-salt diets and exercise for best results. Always consult for personalization, especially in elderly or comorbid patients.\n​\n\nKey Benefits\nBENIPRIME 4 excels in long-term blood pressure reduction, with studies showing sustained drops in brachial-ankle pulse wave velocity beyond mere pressure effects. It protects the heart and kidneys through anti-sclerotic and antioxidant actions, lowering cardiovascular event risks.\n​\n\nPatients experience fewer angina attacks, better endurance, and improved quality of life. The once-daily regimen boosts adherence, while vascular selectivity minimizes reflex tachycardia common in other blockers. Clinical data indicate reduced C-reactive protein and aldosterone, curbing inflammation and fibrosis.\n​\n\nBenefit\tDescription\tSupporting Evidence\nBP Control\tReduces systolic/diastolic pressure effectively over 24 hours \n​\tLong-term studies show persistent effects post-treatment \n​\nHeart Protection\tImproves coronary flow, cuts angina frequency \n​\tMyocardial protection via NO stimulation \n​\nRenal Support\tLowers proteinuria, aids kidney hypertension \n​\tAnti-oxidative vascular benefits \n​\nAdherence Ease\tOnce-daily dosing with sustained release \n​\tHigh membrane affinity for lasting action \n​\nAdditional perks include potential triglyceride reduction and osteoblast stimulation for bone health in hypertensives.\n\nPotential Side Effects\nMost users tolerate BENIPRIME 4 well, with mild, transient effects resolving spontaneously. Common issues include headache, dizziness, flushing, ankle swelling, palpitations, fatigue, nausea, and sleepiness.\n​\n\nLess frequent are constipation, abdominal pain, tinnitus, shoulder stiffness, urinary frequency, or elevated liver enzymes. Rare serious reactions involve severe hypotension, rash, itching, or allergic responses—seek immediate care if these arise. Monitor blood pressure during initiation to avoid drops.\n\nHeart-related: Palpitations, chest pressure\n​\n\nNervous system: Dizziness, headache\n\nSkin/Vascular: Flushing, edema.\n\nGI: Nausea, constipation\n​\n\nLiver/kidney patients need caution; inform doctors of history.\n\n\nPrecautions and Interactions\nAvoid in hypotension, severe aortic stenosis, or hypersensitivity to dihydropyridines. Use cautiously in liver/kidney impairment, pregnancy, or breastfeeding—benefits must outweigh risks. Grapefruit juice may amplify effects; limit alcohol.\n​\n\nIt interacts with beta-blockers, digoxin, or CYP3A4 inhibitors like ketoconazole, potentially enhancing hypotension. Regular monitoring of BP, electrolytes, and renal function is advised during therapy. Abrupt stop may rebound pressure; taper under guidance.\n​\nConclusion\nBENIPRIME 4 with Benidipine 4 mg empowers reliable hypertension and angina control through innovative calcium channel action. Balancing potent benefits like organ protection and ease of use against manageable side effects, it fits seamlessly into modern cardiac care. Consult healthcare providers for tailored integration with lifestyle for lasting heart health. ", "price": 89.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2261, "imageuri": "https://productimages.withfloats.com/actual/6958dbfc615a7d157715572f.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6958dbfc615a7d157715572f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-03T09:06:02.841Z", "updatedon": "2026-01-03T09:06:02.841Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/benidipine-4mg/2261", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BENIPRIME 4", "category": "CARDIOLOGYRANGE", "tags": [ "benidipine 4mg", "benidipine 4mg tab", "benidipine hydrochloride uses.", "benidipine.", "benidipine 4 mg", "benidipine 4", "benidipine maximum dose", "benidipine 4 mg uses.", "benidipine price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-01-08T07:15:13.88Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2026-01-09T07:22:00.365Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin and Linagliptin Tablets", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 324.0, "discountamount": 97.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-12-09T06:36:10.392Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-and-linagliptin-tablets/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EMPATECH LINA 25/5", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets", "help manage blood sugar levels", "2 diabetes mellitus", "Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2)" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66e17c18143af4c013225b9d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Eq . to Sacubitril 49 mg , Valsartan 51 mg", "description": "SACUSMART 10 is a combination medication that contains Sacubitril (49 mg) and Valsartan (51 mg), two potent active ingredients used primarily for managing heart failure. This combination is designed to improve heart function, lower the risk of hospitalization, and enhance the quality of life in patients with chronic heart failure by reducing the strain on the heart. SACUSMART 10 is often prescribed for individuals who need both blood pressure control and heart protection.\n\n \n\nKey Ingredients:\n \n\nSacubitril (49 mg): Sacubitril is a neprilysin inhibitor that helps in the dilation of blood vessels, promoting better blood flow and reducing the strain on the heart.\nValsartan (51 mg): Valsartan is an angiotensin II receptor blocker (ARB), which helps in lowering blood pressure by blocking the action of angiotensin, a substance that tightens blood vessels, leading to improved heart function and reduced hypertension.\n \n\nKey Benefits:\n \n\nImproves Heart Function: SACUSMART 10 is clinically proven to improve heart pumping efficiency in patients with heart failure.\nReduces Hospitalizations: It decreases the likelihood of heart failure-related hospital admissions by managing symptoms more effectively.\nBlood Pressure Management: Valsartan’s ARB action helps in lowering blood pressure, which further reduces the stress on the heart.\nSlows Disease Progression: By improving circulation and reducing the heart’s workload, SACUSMART 10 helps in delaying the progression of heart failure.\nEnhances Quality of Life: Patients often experience reduced symptoms such as shortness of breath and fatigue, allowing for a better quality of life.\n \n\nHow Does It Work?\n \n\nSACUSMART 10 works by combining two mechanisms:\n\nSacubitril inhibits neprilysin, an enzyme that breaks down substances like natriuretic peptides which dilate blood vessels and promote sodium excretion. This action helps reduce the blood pressure and the workload on the heart.\nValsartan, as an ARB, blocks the effects of angiotensin II, preventing blood vessel constriction and reducing blood pressure. Together, these actions improve blood flow, reduce strain on the heart, and help manage heart failure more effectively.\n \n\nDirections for Use:\n \n\nDosage: The dosage is determined by the healthcare provider based on the patient’s condition and medical history. It is typically taken orally, twice daily.\nWith or Without Food: SACUSMART 10 can be taken with or without food. Swallow the tablet whole with water.\nCompliance: For best results, take SACUSMART 10 consistently at the same time each day. Do not stop taking the medication without consulting your healthcare provider.\n \n\nSide Effects:\n \n\nWhile SACUSMART 10 is generally well-tolerated, some patients may experience side effects such as:\n\nDizziness or lightheadedness (especially when standing up too quickly)\nCough\nFatigue\nHypotension (low blood pressure)\nKidney function changes\nElevated potassium levels (hyperkalemia)", "price": 651.0, "discountamount": 326.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "51 mg", "49 mg", "same time", "ARB action", "blood flow", "Side Effects", "best results", "Key Benefits", "Cough Fatigue", "blood vessels", "heart function", "two mechanisms", "medical history", "Key Ingredients", "heart protection", "sodium excretion", "pumping efficiency", "low blood pressure", "Disease Progression", "healthcare provider", "neprilysin inhibitor", "natriuretic peptides", "chronic heart failure", "combination medication", "blood pressure control", "Kidney function changes", "Blood Pressure Management", "blood vessel constriction", "Elevated potassium levels", "two potent active ingredients", "angiotensin II receptor blocker", "heart failure-related hospital admissions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1975, "imageuri": "https://productimages.withfloats.com/actual/6933dca03e6bb33a48420c37.png", "tileimageuri": "https://productimages.withfloats.com/tile/6933dca03e6bb33a48420c37.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-11T11:16:40.793Z", "updatedon": "2025-12-06T07:34:55.69Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/eq-to-sacubitril-49-mg-valsartan-51-mg/1975", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SACUSMART 100 ", "category": "CARDIOLOGYRANGE", "tags": [ "sacubitril and valsartan tablets", "sacubitril and valsartan tablets 50 mg", "sacubitril and valsartan", "sacubitril and valsartan tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66644eb5e69b8516f884ea68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pantoprazole 40mg Itopride 150mg", "description": "PANTOSTRUM IT\nPantoprazole (40mg), Itopride (150mg)\nPANTOSTRUM IT is a scientifically formulated combination of Pantoprazole 40 mg and Itopride 150 mg, designed to provide effective relief from acid-related gastrointestinal disorders and motility problems. This dual-action medicine not only reduces excess stomach acid but also improves digestive movement, making it an ideal treatment for patients suffering from chronic acidity, gastroesophageal reflux disease (GERD), functional dyspepsia, bloating, nausea, and delayed gastric emptying.\n\nDigestive problems such as heartburn, indigestion, and gas can significantly affect daily comfort and quality of life. PANTOSTRUM IT addresses both the cause (excess acid production) and the symptoms (slow gut movement and discomfort), offering comprehensive gastrointestinal support in a single tablet. This combination is widely prescribed by healthcare professionals for long-term acid control and improved digestion.\n\nComposition\n\nPantoprazole 40 mg\n\nItopride Hydrochloride 150 mg\n\nHow PANTOSTRUM IT Works\n\nPANTOSTRUM IT works through a dual-mechanism approach:\n\nPantoprazole is a proton pump inhibitor (PPI) that reduces the production of stomach acid by blocking the acid-secreting pumps in the stomach lining. This helps heal acid-related damage and prevents irritation of the esophagus and stomach.\n\nItopride is a prokinetic agent that enhances gastrointestinal motility by increasing acetylcholine activity. It helps food move smoothly through the digestive tract, reducing bloating, fullness, nausea, and discomfort.\n\nTogether, these two ingredients provide faster symptom relief and long-lasting digestive comfort.\n\nUses of PANTOSTRUM IT\n\nPANTOSTRUM IT is commonly prescribed for the treatment and management of the following conditions:\n\nGastroesophageal Reflux Disease (GERD)\n\nChronic acidity and heartburn\n\nFunctional dyspepsia\n\nAcid reflux and regurgitation\n\nBloating and abdominal discomfort\n\nNausea and vomiting related to gastric disorders\n\nDelayed gastric emptying\n\nPeptic ulcer disease (as supportive therapy)\n\nIndigestion caused by excess acid secretion\n\nThis combination is particularly beneficial for patients who experience acidity along with symptoms of poor digestion or slow stomach movement.\n\nKey Benefits of PANTOSTRUM IT\n1. Effective Acid Control\n\nPantoprazole 40 mg provides powerful and sustained suppression of gastric acid, reducing irritation, pain, and burning sensations in the chest and stomach.\n\n2. Improves Digestive Motility\n\nItopride 150 mg enhances stomach and intestinal movement, helping relieve bloating, heaviness, and early satiety after meals.\n\n3. Dual Symptom Relief\n\nBy targeting both acid secretion and digestive movement, PANTOSTRUM IT offers more complete relief compared to single-ingredient medicines.\n\n4. Reduces Nausea and Vomiting\n\nImproved gastric emptying helps control nausea and vomiting associated with acid reflux and indigestion.\n\n5. Supports Long-Term Gastrointestinal Health\n\nRegular use under medical supervision helps prevent recurrence of acidity-related complications and improves overall digestive comfort.\n\n6. Well-Tolerated Combination\n\nWhen taken as prescribed, PANTOSTRUM IT is generally well tolerated and suitable for long-term management of chronic gastric disorders.\n\nHow to Take PANTOSTRUM IT\n\nPANTOSTRUM IT should be taken exactly as advised by a healthcare professional. It is usually recommended to take the tablet before meals, preferably in the morning, to achieve maximum acid suppression and digestive support. The tablet should be swallowed whole with water and not crushed or chewed.\n\nPossible Side Effects of PANTOSTRUM IT\n\nLike all medications, PANTOSTRUM IT may cause some side effects, although not everyone experiences them. Most side effects are mild and temporary.\n\nCommon Side Effects\n\nHeadache\n\nDiarrhea or constipation\n\nAbdominal pain\n\nNausea\n\nDizziness\n\nFlatulence\n\nLess Common Side Effects\n\nDry mouth\n\nFatigue\n\nSkin rash or itching\n\nMild increase in liver enzymes\n\nRare Side Effects\n\nAllergic reactions\n\nIrregular bowel movements\n\nProlonged use may affect vitamin B12 absorption (under medical supervision)\n\nIf any severe or persistent side effects occur, medical advice should be sought immediately.\n\nPrecautions and Warnings\n\nUse with caution in patients with liver disorders\n\nNot recommended during pregnancy or breastfeeding unless prescribed\n\nLong-term use should be monitored by a healthcare professional\n\nAvoid alcohol as it may worsen gastric irritation\n\nInform your doctor about other medications to avoid interactions\n\nConclusion\n\nPANTOSTRUM IT is a reliable and effective combination of Pantoprazole 40 mg and Itopride 150 mg, offering comprehensive relief from acid-related and motility-related gastrointestinal disorders. By reducing excess acid production and improving digestive movement, it helps restore comfort, prevents recurrence of symptoms, and supports long-term digestive health.\n\n\n\n\n\n", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GERD", "Call", "PPIs", "Email", "drugs", "class", "usage", "relief", "ulcers", "doctor", "dosage", "safety", "Itopride", "efficacy", "WhatsApp", "heartburn", "dyspepsia", "conditions", "indigestion", "information", "sterispharma", "instructions", "sterisonline", "Pantoprazole", "regurgitation", "PANTOSTRUM IT", "gastroparesis", "gastric emptying", "prokinetic agent", "digestive motility", "acid reflux symptoms", "combination medication", "acid-related disorders", "proton pump inhibitors", "stomach acid production", "healthcare professionals", "gastrointestinal motility", "gastrointestinal disorders", "gastroesophageal reflux disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1600, "imageuri": "https://productimages.withfloats.com/actual/66644ebd2763378392d54576.png", "tileimageuri": "https://productimages.withfloats.com/tile/66644ebd2763378392d54576.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T12:29:41.206Z", "updatedon": "2026-01-31T11:16:42.583Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pantoprazole-40mg-itopride-150mg/1600", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANTOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "PANTOSTRUM IT", "Pantoprazole (40mg)", "Itopride (150mg)", "Itopride 150mg uses", "pantoprazole 40mg + itopride 150mg", "Itopride side effects", "Itopride dose", "pantoprazole 40mg itopride 150mg tablets", "pantoprazole itopride combination tablets", "pantoprazole itopride for indigestion", "pantoprazole itopride tablets for gas", "pantoprazole itopride uses and benefits", "pantoprazole itopride for stomach pain", "pantoprazole itopride side effects", "pantoprazole 40mg itopride 150mg price", "pantoprazole itopride tablets price in India", "pantoprazole itopride supplier in India", "pantoprazole itopride gastro medicine", "pantoprazole itopride for functional dyspepsia" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }